Talcum Powder Lawsuit Overview

talcum powder lawsuit informationJohnson & Johnson’s iconic Johnson’s baby powder® as well as Shower to Shower® products both include the mineral talc, which is a silicate. However, talcum powder is linked to ovarian cancer in women using talc-based products for feminine hygiene. As a result, injured patients may qualify for compensation through a talcum powder lawsuit.

Johnson & Johnson, the world’s largest manufacturer and distributor of talcum powders, has sold talc-based products for over 100 years. Further, the company continues to do so today without adding product warning labels to inform consumers about any potential risks.

The Link Between Talcum Powder and Ovarian Cancer

Talcum powder is one of the most common hygiene products on the market today. Due to its supposed ability to absorb moisture as well as reduce rashes, talc’s popularity among consumers remains strong. Talcum powder contains talc, a seemingly non-complex combination of magnesium, silicon and oxygen. However, talc is also a silicate, which many doctors agree can cause inflammation in the body.

Since the 1970s, researchers speculated about the potential link between talcum powder and the risk of developing ovarian cancer. Because studies show an association between the two, recent allegations have surfaced in talcum powder lawsuits. Plaintiffs now claim the company knew about the link between talc and increased risk of cancer. However, J&J failed to properly warn consumers about potential dangers from using talcum powder products in the genital region.

Researchers Cite Dangers of Prolonged Genital Talc Use

Surprisingly, a study conducted in 1971 discovered that talc was in an overwhelming 75% of ovarian tumors. Then in 1973, the Federal Drug Administration required all talcum powders to be asbestos-free by law. Nearly 20 years later, a 1992 study found that women who applied talcum powder in the genital region had an elevated risk of developing epithelial ovarian cancer. Further, researchers published a 2003 case-control study stating that talcum powder increased women’s risk of ovarian cancer by 33% when regularly applied near the genitals.

Due to Johnson & Johnson’s failure to warn consumers about the link between cancer and talcum powder shown over decades of published medical research, many people were unknowingly exposed to serious, life-threatening danger.

Talcum Powder Lawsuit Information

Deane Berg won the first talcum powder lawsuit in federal court against Johnson & Johnson in 2013. Because of this benchmark lawsuit, thousands of women diagnosed with ovarian cancer after using talcum powder have hope for justice. In yet another case, Missouri jurors awarded the first talcum powder settlement for $72 million to Jacqueline Fox’s family in 2016. Fox’s ovarian cancer diagnosis resulted in death after decades of using talc-based products for feminine hygiene. As a result, Johnson & Johnson paid both actual and punitive damages to Fox’s son, Marvin Salter.

Juries ruled in favor of two additional plaintiffs in cases against Johnson & Johnson throughout 2016. Gloria Ristesund won a $55 million payout for her ovarian cancer verdict in May. Then in October, Deborah Giannecchini won a $70 million talcum powder lawsuit settlement. Due to talcum powder’s popularity, thousands of potential negligence claims are still pending against Johnson & Johnson.

J&J Talcum Powder Lawsuit Payouts in 2017

In 2017, juries ordered J&J to pay nearly a billion dollars in talcum powder lawsuit settlements. One Virginia woman who developed ovarian cancer won $110 million from her talcum powder lawsuit verdict, which another court upheld in November 2017. However, appeals courts overturned two previous verdicts; both plaintiffs in those cases passed away before they could receive their payouts.

Check your eligibility for compensation.

If you or a loved one has suffered from ovarian cancer after talcum powder use, you may be entitled to compensation from the manufacturer. Request your free case evaluation now to see if you may qualify.